Marker Therapeutics, Inc. (MRKR) — Institutional Holders, Q2 2026

35 institutional investment managers reported a MRKR position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $5.8M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.

MRKR in Q2 2026: what funds did

Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.

New positions

4

Added to

6

Trimmed

7

Sold out

5

Biggest buyers

  1. RENAISSANCE TECHNOLOGIESAdded · +74,129 sh+$109.0K
  2. Concurrent Investment AdvisorsNew · +67,963 sh+$99.9K
  3. VANGUARD CAPITAL MANAGEMENTAdded · +36,850 sh+$54.2K
  4. CITADEL ADVISORSNew · +32,517 sh+$47.8K
  5. OSAICAdded · +19,528 sh+$28.7K

Biggest sellers

  1. SUSQUEHANNA INTERNATIONAL GROUP, LLPSold out · -48,780 sh-$71.7K
  2. UBS Group AGTrimmed · -24,219 sh-$35.6K
  3. GEODE CAPITAL MANAGEMENTTrimmed · -21,094 sh-$31.0K
  4. JANE STREET GROUPTrimmed · -19,471 sh-$28.6K
  5. XTX Topco LtdTrimmed · -18,210 sh-$26.8K

MRKR 13F holders ranked 1–35 of 35

Institutional investors reporting a position in Marker Therapeutics, Inc. on SEC Form 13F-HR for Q2 2026, ranked by reported value.
InstitutionValueQoQ
NEA Management Company#1 · 1,625,678 sh$2.4M0.0%
Blue Owl Capital#2 · 554,250 sh$814.7K0.0%
VANGUARD CAPITAL MANAGEMENT#3 · 426,169 sh$626.5K+9.5%
Aisling Capital Management#4 · 325,370 sh$478.3K0.0%
RENAISSANCE TECHNOLOGIES#5 · 249,423 sh$366.7K+42.3%
GEODE CAPITAL MANAGEMENT#6 · 139,816 sh$205.6K-13.1%
OSAIC#7 · 112,649 sh$165.6K+21.0%
VANGUARD FIDUCIARY#8 · 87,269 sh$128.3K0.0%
LPL Financial#9 · 83,147 sh$122.2K+0.1%
Concurrent Investment Advisors#10 · 67,963 sh$99.9KNew
TWO SIGMA INVESTMENTS#11 · 60,201 sh$88.5K-1.3%
XTX Topco Ltd#12 · 45,357 sh$66.7K-28.6%
NORTHERN#13 · 34,629 sh$50.9K+33.1%
CITADEL ADVISORS#14 · 32,517 sh$47.8KNew
STATE STREET#15 · 20,948 sh$30.8K0.0%
Invst#16 · 18,000 sh$26.5K-37.9%
Creative Planning#17 · 17,312 sh$25.4K0.0%
JANE STREET GROUP#18 · 16,832 sh$24.7K-53.6%
Ashton Thomas Private Wealth#19 · 16,400 sh$24.1K0.0%
Virtu Financial#20 · 11,574 sh$17.0KNew
FIFTH THIRD BANCORP#21 · 10,000 sh$14.7K0.0%
UBS Group AG#22 · 8,150 sh$12.0K-74.8%
Vanguard Global Advisers#23 · 2,512 sh$3.7K0.0%
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT#24 · 2,000 sh$2.9K0.0%
Tower Research Capital (TRC)#25 · 810 sh$1.2K-74.2%
WELLS FARGO & COMPANY#26 · 232 sh$341.000.0%
SIGNATUREFD#27 · 228 sh$335.000.0%
SBI Securities , Ltd.#28 · 203 sh$298.000.0%
GROUP ONE TRADING, L.P.#29 · 178 sh$262.000.0%
Hilltop National Bank#30 · 73 sh$107.000.0%
BARCLAYS PLC#31 · 63 sh$93.00New
BNP PARIBAS FINANCIAL MARKETS#32 · 23 sh$34.000.0%
JPMORGAN CHASE#33 · 23 sh$34.000.0%
Caitong International Asset Management , Ltd#34 · 9 sh$13.00+200.0%
MORGAN STANLEY#35 · 2 sh$2.000.0%

Funds that sold out of MRKR in Q2 2026 (5)

Held MRKR at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.

Institutions that held MRKR in Q1 2026 and reported no position in Q2 2026.
InstitutionValue in Q1 2026
SUSQUEHANNA INTERNATIONAL GROUP, LLP48,780 sh$63.4K
MATRIX ASSET ADVISORS15,000 sh$19.5K
HRT FINANCIAL11,852 sh$15.0K
TWO SIGMA SECURITIES11,460 sh$14.9K
Western Wealth Management368 sh$478.00

Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.